• 1. Estimating and correcting interference fringes in infrared spectra in infrared hyperspectral imaging
  Ghazal Azarfar,Ebrahim Aboualizadeh,Nicholas M. Walter,Simona Ratti,Camilla Olivieri,Alessandra Norici,Michael Nasse,Achim Kohler,Mario Giordano Analyst, 2018,143, 4674-4683
• 2. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 3. Feasibility of polyethylene composites reinforced by distillers dried fibers with solubles (DDFS) after different generations of ethanol fermentation?
  Bo Chen,Xiaotong Shen,Zhangfeng Luo,Di Cai,Changjing Chen,Changwei Zhang,Peiyong Qin,Hui Cao,Tianwei Tan RSC Adv., 2018,8, 25602-25610
• 4. Excellent energy storage performance in NaNbO3-based relaxor antiferroeic ceramics under a low electric field
  XuxinCheng,XiaomingChen,PengyuanFan
• 5. Expanding nanoparticle multifunctionality: size-selected cargo release and multiple logic operations?
  Danlei Xiang Nanoscale, 2021,13, 5497-5506

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Diphenylethers

Introduction to Fenoprofen Calcium Hydrate (CAS No. 53746-45-5)

Fenoprofen Calcium Hydrate, identified by the Chemical Abstracts Service Number (CAS No.) 53746-45-5, is a widely recognized pharmaceutical compound belonging to the propionic acid derivative class. This compound is primarily utilized in the medical field as an effective nonsteroidal anti-inflammatory drug (NSAID), offering significant therapeutic benefits in managing pain, inflammation, and fever. The hydrated form of fenoprofen calcium enhances its solubility and bioavailability, making it a preferred choice in various formulations.

The pharmacological properties of Fenoprofen Calcium Hydrate stem from its ability to inhibit cyclooxygenase (COX) enzymes, which are crucial in the synthesis of prostaglandins—mediators of inflammation and pain. By selectively targeting COX-1 and COX-2 enzymes, this compound effectively reduces the production of prostaglandins, thereby alleviating symptoms associated with conditions such as arthritis, musculoskeletal pain, and post-operative discomfort. The calcium salt form further improves its stability and compatibility with different pharmaceutical matrices.

Recent advancements in pharmaceutical research have highlighted the potential of Fenoprofen Calcium Hydrate in combination therapies. Studies have demonstrated its synergistic effects when used alongside other anti-inflammatory agents, enhancing overall therapeutic outcomes. Additionally, novel delivery systems such as controlled-release formulations have been explored to prolong the drug's action, reduce side effects, and improve patient compliance. These innovations underscore the compound's versatility and ongoing relevance in modern medicine.

The chemical structure of Fenoprofen Calcium Hydrate (CAS No. 53746-45-5) consists of a propionic acid moiety linked to an isobutyl group, with calcium ions facilitating hydration. This unique configuration contributes to its high affinity for biological targets while maintaining a favorable pharmacokinetic profile. The compound's solubility in water and polar solvents further facilitates its incorporation into diverse dosage forms, including tablets, capsules, and oral suspensions.

In clinical settings, Fenoprofen Calcium Hydrate has been extensively studied for its efficacy and safety profile. Clinical trials have consistently shown its effectiveness in reducing pain intensity and improving functional mobility in patients with osteoarthritis and rheumatoid arthritis. Moreover, its minimal impact on gastrointestinal mucosa compared to some other NSAIDs makes it a suitable option for long-term management of chronic inflammatory conditions.

The synthesis of Fenoprofen Calcium Hydrate involves well-established chemical processes that ensure high purity and yield. Advanced synthetic methodologies have been refined to optimize reaction conditions, minimize by-products, and enhance scalability for industrial production. These improvements have not only improved the cost-effectiveness of the compound but also ensured consistent quality across batches.

Regulatory agencies worldwide have approved Fenoprofen Calcium Hydrate for use in various therapeutic indications, recognizing its therapeutic value and safety profile. Compliance with Good Manufacturing Practices (GMP) ensures that pharmaceutical manufacturers maintain stringent quality control measures throughout the production process. This adherence to regulatory standards guarantees that patients receive high-quality medications that meet rigorous safety and efficacy criteria.

Future research directions for Fenoprofen Calcium Hydrate include exploring its potential in additional therapeutic areas beyond traditional anti-inflammatory applications. Investigating its role in modulating immune responses and its interactions with other biological pathways may uncover new clinical uses. Furthermore, nanotechnology-based delivery systems are being explored to enhance drug targeting and bioavailability, potentially revolutionizing how this compound is administered.

The environmental impact of pharmaceutical compounds is also a growing concern. Sustainable manufacturing practices for Fenoprofen Calcium Hydrate are being developed to minimize waste generation and reduce energy consumption during production. These efforts align with global initiatives to promote green chemistry principles, ensuring that pharmaceutical development remains environmentally responsible while maintaining high therapeutic standards.

In conclusion, Fenoprofen Calcium Hydrate (CAS No. 53746-45-5) remains a cornerstone in the management of inflammatory and painful conditions due to its well-established efficacy, safety profile, and versatile formulation options. Ongoing research continues to uncover new applications and improve delivery systems for this compound, reinforcing its importance in contemporary healthcare practices.

• 31879-05-7(2-(3-PHENOXYPHENYL)PROPANOIC Acid)
• 32953-79-0(R(-)-Fenoprofen)
• 29679-58-1(Fenoprofen)
• 37785-47-0(Benzeneacetic acid, 4-hydroxy-a-methyl-3-phenoxy-)
• 17653-94-0(2-(3-Methoxyphenyl)-2-methylpropanoic acid)
• 71720-56-4(Fenoprofen Calcium hydrate)
• 33028-97-6(Benzeneacetic acid, a-methyl-3-phenoxy-, (aS)-)
• 66424-46-2(Fenoprofen Sodium Salt Dihydrate)
• 34597-40-5(Fenoprofen Calcium)
• 942-54-1(2-(4-Methoxyphenyl)propanoic acid)